GeneNovate® is a nationwide, free-of-charge entrepreneurship program for students, PhD candidates, postdocs, researchers, and physicians interested in developing innovative ideas in gene and cell therapies, biotechnology, and life sciences into…
Artificial intelligence (AI) is transforming healthcare at a rapid pace. It is changing how health data are collected, interpreted and applied across areas ranging from basic research and drug development to diagnostics, clinical decision support,…
Neurotech is reshaping the diagnosis and treatment of neurological and psychiatric disorders. In Berlin Brandenburg, the field is moving from research into practical application through brain-computer interfaces, digital therapies and non-invasive…
Eckert & Ziegler Brazil, a regional subsidiary of the global nuclear medicine group Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), and TerThera announced today the signing of a strategic supply agreement for the precursor Terbium-161.
The Berlin Center for HIV Cure bundles interdisciplinary expertise on HIV and provides access to the latest, leading-edge clinical trials
B# Plus stärkt Berliner Biotech-Gründerinnen bei der Entwicklung einer wegweisenden Gen-Reparaturtherapie gegen genetisch bedingten Muskelschwund.
Doctolib, Europe’s leading healthtech company, is building its AI solutions and models in Europe, for health professionals and patients. Doctolib is advancing this work with a planned minority investment from NVIDIA. The investment will support…
Aggressive tumors often contain large amounts of exchromosomal DNA. Removing this DNA from the nuclei of cancer cells could improve patient outcomes, an international team led by Anton Henssen of the Experimental and Clinical Research Center reports…
Building on five years of successful collaboration, the WHO Hub for Pandemic and Epidemic Intelligence in Berlin, which is part of the WHO Health Emergencies Programme, the Robert Koch Institute (RKI), Germany’s central national public health agency,…
Application Deadline: 20 October, 2026
